The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...
The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...
The FDA is eliminating “unnecessary testing” on animals, according to Commissioner Marty Makary. He joined “Katie Pavlich ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental drugs and adopt newer methods, such as computer ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...
New draft guidance from the FDA is urging pharma companies to accelerate efforts to transition from animal testing to ...
Officials with the FDA have released a draft guidance that aims to help drug developers validate new approach methodologies (NAMs) that can be used in place of animal testing. Based on human-centric ...
Animal studies often fail to predict human tissue responses to new drugs or newly developed therapies. Besides generating tremendous costs for clinical studies, it also raises significant ethical ...
Experiments on animals (“in vivo” experiments) have long been the norm for learning about human health and disease, because testing on live animals enables researchers to investigate how chemicals, ...
The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as alternatives to animal testing in preclinical drug development. The guidance, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results